Loading stock data...

Vimta Labs Limited

NSE: VIMTALABS BSE: VIMTALABS

NSE
789.90 12.95 (1.67%)

Prev Close

776.95

Open Price

782

Volume

902,933

Today Low / High

771.1 / 799.4

52 WK Low / High

251.525 / 902.65

Range

750 - 829

BSE
790.55 13.70 (1.76%)

Prev Close

776.85

Open Price

782

Volume

110,820

Today Low / High

772.3 / 799.25

52 WK Low / High

254.425 / 902.85

Range

751 - 830

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 789.9 (target range: 750 - 829), reflecting a change of 12.95 (1.66677%). On the BSE, it is listed at 790.55 (target range: 751 - 830), showing a change of 13.7 (1.76353%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

12 Sep 786.00 -1.15%
11 Sep 802.55 -2.82%
10 Sep 823.95 -3.33%
09 Sep 840.90 -2.17%
08 Sep 880.00 -5.27%
05 Sep 800.00 9.65%
04 Sep 815.00 -2.28%
03 Sep 792.10 2.52%
02 Sep 656.80 16.31%
01 Sep 667.10 -1.99%
29 Aug 658.00 1.25%
28 Aug 631.25 4.20%
26 Aug 647.00 -2.43%
25 Aug 660.00 -1.95%
22 Aug 706.50 -6.90%
21 Aug 710.00 0.31%
20 Aug 669.80 5.61%
19 Aug 664.00 0.18%
18 Aug 665.00 -0.13%

Vimta Labs Limited Graph

Vimta Labs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Vimta Labs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 789.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 790.55 798.46 718.61 - 878.30
806.36 645.09 - 967.63
814.27 569.99 - 1,058.55
Bearish Scenario 790.55 782.64 704.38 - 860.91
774.74 619.79 - 929.69
766.83 536.78 - 996.88

Overview of Vimta Labs Limited

ISIN

INE579C01029

Industry

Medical - Diagnostics & Research

Vol.Avg

3,314,625

Market Cap

34,578,625,920

Last Dividend

1

Official Website

Visit Website

IPO Date

2005-12-15

DCF Diff

-1,022.83

DCF

1,805

Financial Ratios Every Investor Needs

Stock Dividend of VIMTALABS

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-05-30 May 30, 25 1 1 2025-05-30 2025-06-16
2024-07-11 July 11, 24 2 2 2024-07-11 2024-07-25
2023-06-21 June 21, 23 2 2 2023-06-21 2023-07-07
2022-06-16 June 16, 22 2 2 2022-06-18 2022-06-30
2021-06-25 June 25, 21 2 2 2021-06-28 2021-07-12

Stock Rating Details for VIMTALABS

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 343.98 Cr 211.38 Cr 132.60 Cr 0.3855 0.00 Cr 100.59 Cr 87.82 Cr 67.34 Cr 15.14 126.19 Cr 0.1958
2024-03-31 318.26 Cr 76.29 Cr 241.98 Cr 0.7603 0.00 Cr 10.28 Cr 57.51 Cr 41.01 Cr 9.26 90.20 Cr 0.1289
2023-03-31 315.06 Cr 73.85 Cr 241.21 Cr 0.7656 0.00 Cr 10.93 Cr 69.68 Cr 48.17 Cr 10.89 96.64 Cr 0.1529
2022-03-31 275.94 Cr 79.20 Cr 196.75 Cr 0.7130 0.00 Cr 8.60 Cr 55.33 Cr 41.33 Cr 9.35 79.84 Cr 0.1498
2021-03-31 208.57 Cr 61.11 Cr 147.45 Cr 0.7070 1.12 Cr 7.75 Cr 36.08 Cr 21.41 Cr 9.68 53.35 Cr 0.1026

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 15.84 Cr 466.53 Cr 87.68 Cr 378.8480 Cr 8.52 Cr -24.43 Cr 25.06 Cr 261.67 Cr 0.00 Cr 8.22 Cr 0.00 Cr 64.3670 Cr
2024-03-31 13.44 Cr 400.05 Cr 80.35 Cr 319.6960 Cr 19.19 Cr 5.75 Cr 24.69 Cr 216.75 Cr 0.00 Cr 5.33 Cr -9.36 Cr 54.0700 Cr
2023-03-31 30.50 Cr 362.33 Cr 80.54 Cr 281.7860 Cr 14.99 Cr -15.51 Cr 22.62 Cr 171.67 Cr 4.90 Cr 4.52 Cr -6.00 Cr 57.2770 Cr
2022-03-31 10.80 Cr 307.20 Cr 73.21 Cr 233.9840 Cr 19.34 Cr 8.54 Cr 17.38 Cr 150.86 Cr 4.79 Cr 5.58 Cr 0.00 Cr 47.7490 Cr
2021-03-31 6.19 Cr 274.36 Cr 79.98 Cr 194.3820 Cr 30.42 Cr 24.22 Cr 14.64 Cr 147.95 Cr 4.14 Cr 3.84 Cr 0.00 Cr 53.9110 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 94.8300 Cr -75.5370 Cr -16.6810 Cr 15.7660 Cr 2.3950 Cr 15.8360 Cr -79.4940 Cr 66.7550 Cr -10.9260 Cr -4.4340 Cr -0.3660 Cr
2024-03-31 60.8920 Cr -76.0480 Cr -1.9030 Cr -15.6780 Cr -17.0590 Cr 13.4410 Cr -76.3340 Cr 41.0090 Cr 4.0010 Cr -4.4280 Cr -2.0680 Cr
2023-03-31 87.9370 Cr -57.2560 Cr -10.9810 Cr 38.1320 Cr 19.7000 Cr 30.5000 Cr -47.8190 Cr 64.9970 Cr -5.6780 Cr -4.4220 Cr -5.2460 Cr
2022-03-31 59.0690 Cr -37.8480 Cr -16.6140 Cr 20.3450 Cr 4.6070 Cr 10.8000 Cr -29.7830 Cr 55.6850 Cr -11.4150 Cr -4.4220 Cr -2.7420 Cr
2021-03-31 37.1820 Cr -31.9240 Cr -4.5700 Cr 4.0930 Cr 0.6880 Cr 6.1930 Cr -33.0890 Cr 28.5400 Cr -2.8450 Cr 0.0000 Cr 2.4950 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 97.56 Cr 56.49 Cr 41.08 Cr 0.4210 23.83 Cr 18.89 Cr 4.25 35.44 Cr 0.1937
2025-03-31 94.44 Cr 54.65 Cr 39.79 Cr 0.4213 23.83 Cr 18.32 Cr 8.22 34.68 Cr 0.1940
2024-12-31 89.92 Cr 20.63 Cr 69.29 Cr 0.7706 23.28 Cr 21.50 Cr 4.83 34.31 Cr 0.2390
2024-09-30 84.74 Cr 18.35 Cr 66.39 Cr 0.7835 21.61 Cr 17.02 Cr 3.44 30.59 Cr 0.2008
2024-06-30 81.76 Cr 18.72 Cr 63.04 Cr 0.7711 17.95 Cr 12.28 Cr 2.77 25.21 Cr 0.1502

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 15.84 Cr 16.89 Cr 32.72 Cr 106.32 Cr 25.06 Cr 187.82 Cr 261.67 Cr 466.53 Cr 87.68 Cr
2024-12-31 0.00 Cr 0.00 Cr 27.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -342.74 Cr
2024-09-30 14.27 Cr 15.84 Cr 30.11 Cr 92.67 Cr 26.33 Cr 171.94 Cr 244.53 Cr 440.41 Cr 97.67 Cr
2024-06-30 -25.16 Cr 50.32 Cr 25.16 Cr 0.00 Cr 0.00 Cr 25.16 Cr 0.00 Cr 0.00 Cr -319.70 Cr
2024-03-31 13.44 Cr 12.16 Cr 25.79 Cr 87.00 Cr 24.69 Cr 157.60 Cr 216.75 Cr 400.05 Cr 80.35 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 17.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 21.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 15.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 12.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 12.35 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 13.44 Cr 43.55 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2006-02-24 February 24, 06 5:1

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹3,304.40 ₹276,086,049,967.00 ₹66,774.00
Vijaya Diagnostic Centre Limited VIJAYA ₹1,047.00 ₹107,553,012,180.00 ₹23,307.00
Metropolis Healthcare Limited METROPOLIS ₹2,030.90 ₹105,200,975,408.00 ₹63,625.00
Thyrocare Technologies Limited THYROCARE ₹1,184.40 ₹62,766,567,360.00 ₹88,375.00
Vimta Labs Limited VIMTALABS ₹790.15 ₹35,166,099,840.00 ₹889,921.00
Krsnaa Diagnostics Limited KRSNAA ₹839.00 ₹27,216,044,130.00 ₹27,665.00

Key Executives

Senior Vice President of Preclinical
Dr. Upendra Bhatnagar

Gender: Not Specified

Year Born:

Executive Director of Operations, Member of Scientific Advisory Board & Executive Director
Mr. Harriman Vungal D.Tech

Gender: male

Year Born: 1951

Chief Financial Officer
Mr. Siva Rama Krishna Kambhampati

Gender: male

Year Born:

MD & Whole Time Director
Ms. Harita Vasireddi

Gender: female

Year Born: 1974

Company Secretary & Compliance Officer
Ms. Sujani Vasireddi

Gender: female

Year Born: 1976

Executive Chairman
Dr. Sivalinga Prasad Vasireddi

Gender: Not Specified

Year Born: 1948

Executive Director
Mr. Satya Sreenivas Neerukonda

Gender: male

Year Born: 1976

FAQs about Vimta Labs Limited

Who is the CEO of the company?

The CEO is Sivalinga Prasad Vasireddi.

What is the current market price of the stock?

The current price is ₹776.95.

What is the 52-week price range?

The range is ₹251.525-902.65.

What is the market capitalization of the company?

The market capitalization is ₹3,457.86 crores.

What is the dividend yield?

The dividend yield is 0.13%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 45.61.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Vimta Labs Limited (ISIN: INE579C01029) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹3,457.86 crores and an average daily volume of 3,314,625 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹1.